QuickView for cellular response to diacyl bacterial lipopeptide (biogroup)

1. Cerebral organoids with CRISPR-Cas9 induced APOE E3E3 allele expression
2. Brain transcriptome changes 6 and 24 hours after ischemic event
3. Dermal macrophages, epidermal Langerham Cells and CD14+ cells subsets
4. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for cellular response to diacyl bacterial lipopeptide

There were no clinical trials for cellular response to diacyl bacterial lipopeptide